Elanco (ELAN) CFO Robert VanHimbergen Buys Stock

What Happened

• Robert M. VanHimbergen, Executive Vice President and CFO of Elanco Animal Health Inc. (ELAN), made an open-market purchase of 4,200 shares on August 7, 2026 at a weighted average price of $23.08 per share (total ≈ $96,926).
• On the same date he was also granted 8.907 deferred stock units valued at $22.12 each (total ≈ $197). The purchase (code P) is a direct buy; the grant (code A) is a derivative/award.

Key Details

• Transaction dates: August 7, 2026; Form 4 filed August 10, 2026 (appears timely — filed within routine SEC reporting window).
• Open-market purchase: 4,200 shares at weighted avg $23.08; purchase prices ranged $23.01–$23.09 (footnote F1).
• Award: 8.907 deferred stock units at $22.12 each (footnote F2/F3) — these units represent the right to one share or the cash equivalent and settle in cash or shares per the Executive Deferral and Stock Match Plan.
• Shares owned after the transaction: not specified in the provided data.
• Footnotes: F1 notes the weighted-average price and availability of per-price details on request; F2/F3 explain deferred stock units and settlement terms. No 10b5-1 plan, tax-withholding, or late-filing flags were indicated in the provided summary.

Context

• Purchases by executives can be viewed by retail investors as a positive signal because they increase the insider's ownership, but filing this does not explain motivation.
• The deferred stock units are an award, not an immediate sale or exercised option; settlement will follow plan rules (cash or shares, often upon termination or in specified future years).